RyboDyn expands strategic cancer immunotherapy collaboration with Moffitt Cancer Center

UT Southwestern breaks ground on $177M radiation oncology campus in Fort Worth

UT Southwestern Medical Center broke ground May 12 on a $177 million radiation oncology campus that will provide advanced therapies for patients of Fort Worth, TX, the nation’s 12th-largest city.

May 16, 2025

Vol.51 No.19

In Brief

City of Hope opens largest outpatient cancer center in its national system

City of Hope opened its largest outpatient facility among its network of 38 U.S. locations—Hope Plaza.

May 16, 2025

Vol.51 No.19

In Brief

RWJBarnabas Health, Rutgers open NJ’s first and only freestanding cancer hospital

RWJBarnabas Health and Rutgers Cancer Institute, the state’s only NCI-designated Comprehensive Cancer Center, have opened New Jersey’s first and only freestanding, fully comprehensive cancer hospital (The Cancer Letter, April 25, 2025).

May 16, 2025

Vol.51 No.19

In Brief

OncoHost awarded €2.5M grant from the EIC Transition Programme to advance precision oncology

OncoHost, together with its partners Heidelberg University Hospital, European Institute of Oncology and Virgen Macarena University Hospital, announced on May 15 that the parties have been awarded a €2.5 million grant from the EIC Transition Program of Horizon Europe.

May 16, 2025

Vol.51 No.19

Clinical

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

When Kelly Spill was eight months pregnant, she experienced some constipation and noticed blood in her stool. Her OBGYN wasn’t worried.

May 02, 2025

Vol.51 No.17

By Jacquelyn Cobb

RyboDyn expands strategic cancer immunotherapy collaboration with Moffitt Cancer Center

YOU MAY BE INTERESTED IN

UT Southwestern breaks ground on $177M radiation oncology campus in Fort Worth

City of Hope opens largest outpatient cancer center in its national system

RWJBarnabas Health, Rutgers open NJ’s first and only freestanding cancer hospital

OncoHost awarded €2.5M grant from the EIC Transition Programme to advance precision oncology

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

Renew today!

Subscriber content

Never miss an issue!

Login

RyboDyn expands strategic cancer immunotherapy collaboration with Moffitt Cancer Center

YOU MAY BE INTERESTED IN

UT Southwestern breaks ground on $177M radiation oncology campus in Fort Worth

City of Hope opens largest outpatient cancer center in its national system

RWJBarnabas Health, Rutgers open NJ’s first and only freestanding cancer hospital

OncoHost awarded €2.5M grant from the EIC Transition Programme to advance precision oncology

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child

Never miss an issue!

Login

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child